Floatz logo

Prednisone

Limb-Girdle Muscular Dystrophy

Northwestern UniversitySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Limb-Girdle Muscular Dystrophy cohort.

Asset / SponsorPhaseRating
Lisinopril
Cooperative International Neuromuscular Research Group
Phase 2/3B
coq10
Cooperative International Neuromuscular Research Group
Phase 2/3B
Stamulumab
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1/2CCC

Same molecule, other indications

Prednisone is also rated in:

peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →